SARS-CoV-2 spike E484K mutation reduces antibody neutralisation

Saved in:
Bibliographic Details
Published inThe Lancet. Microbe Vol. 2; no. 7; pp. e283 - e284
Main Authors Jangra, Sonia, Ye, Chengjin, Rathnasinghe, Raveen, Stadlbauer, Daniel, Alshammary, Hala, Amoako, Angela A., Awawda, Mahmoud H., Beach, Katherine F, Bermúdez-González, Maria C., Chernet, Rachel L., Eaker, Lily Q., Ferreri, Emily D., Floda, Daniel L., Gleason, Charles R., Kleiner, Giulio, Jurczyszak, Denise, Matthews, Julia C., Mendez, Wanni A., Mulder, Lubbertus C.F., Russo, Kayla T., Salimbangon, Ashley-Beathrese T., Saksena, Miti, Shin, Amber S., Sominsky, Levy A., Srivastava, Komal, Krammer, Florian, Simon, Viviana, Martinez-Sobrido, Luis, García-Sastre, Adolfo, Schotsaert, Michael
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.07.2021
The Author(s). Published by Elsevier Ltd
Elsevier
Subjects
Antibodies, Neutralizing - genetics
Correspondence
COVID-19
Humans
Infectious Disease
Mutation
SARS-CoV-2 - genetics
Spike Glycoprotein, Coronavirus - genetics
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
content type line 23
ISSN:2666-5247
2666-5247
DOI:10.1016/S2666-5247(21)00068-9